These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8552208

  • 1. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS, Raval GN, Rawal RM, Patel GH, Balar DB, Shah PM, Patel DD.
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [Abstract] [Full Text] [Related]

  • 2. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, Dema A, Kotsovoulou V, Pavlidis N.
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [Abstract] [Full Text] [Related]

  • 3. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E, Chondros K, Kouvaris J, Kakari S, Papavassiliou K.
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [Abstract] [Full Text] [Related]

  • 5. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [Abstract] [Full Text] [Related]

  • 6. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R, Caffier H, Paulick M.
    Cancer Detect Prev; 1987 Dec; 10(3-4):197-203. PubMed ID: 3568016
    [Abstract] [Full Text] [Related]

  • 7. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
    Gail MH, Muenz L, McIntire KR, Radovich B, Braunstein G, Brown PR, Deftos L, Dnistrian A, Dunsmore M, Elashoff R.
    J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
    [Abstract] [Full Text] [Related]

  • 8. Serum total sialic acid and regan isoenzyme levels in patients with lung cancer.
    Patel PS, Baxi BR, Desai SS, Balar DB.
    Indian J Pathol Microbiol; 1990 Apr; 33(2):124-8. PubMed ID: 2391142
    [Abstract] [Full Text] [Related]

  • 9. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [Abstract] [Full Text] [Related]

  • 10. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
    Patel PS, Raval GN, Rawal RR, Patel GH, Balar DB, Shah PM, Patel DD.
    Cancer Lett; 1994 Jul 29; 82(2):129-33. PubMed ID: 8050082
    [Abstract] [Full Text] [Related]

  • 11. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B, Krasnodebski IW, Tadeusiak W.
    Pol Tyg Lek; 1994 Jul 29; 46(45-47):890-1. PubMed ID: 1669462
    [Abstract] [Full Text] [Related]

  • 12. Serum sialic acid--an important cancer marker.
    Tewarson SL, Mittal VP, Singh M, Gupta GP.
    Indian J Cancer; 1993 Sep 29; 30(3):125-31. PubMed ID: 8300142
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R, Caffier H, Horner G, Lang K, Filbry E.
    Cancer Detect Prev; 1985 Sep 29; 8(1-2):115-20. PubMed ID: 4064031
    [Abstract] [Full Text] [Related]

  • 14. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS, Rawal GN, Balar DB.
    Gynecol Oncol; 1993 Sep 29; 50(3):294-9. PubMed ID: 8406190
    [Abstract] [Full Text] [Related]

  • 15. Total and lipid-bound serum sialic acid in children with malignancy or infections.
    Romppanen J, Petäjä J, Heikinheimo M, Mononen I.
    Anticancer Res; 1998 Sep 29; 18(4B):2793-7. PubMed ID: 9713463
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M, Chondros K, Ferderigos AS, Daganou M, Dema A, Dalamaga A, Kakari S, Stringou E.
    Anticancer Res; 1992 Sep 29; 12(4):1267-70. PubMed ID: 1503419
    [Abstract] [Full Text] [Related]

  • 17. Significance of serum sialoglycoproteins in patients with lung cancer.
    Patel PS, Baxi BR, Balar DB.
    Neoplasma; 1989 Sep 29; 36(1):53-9. PubMed ID: 2539569
    [Abstract] [Full Text] [Related]

  • 18. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G, Ferrigno D.
    J Thorac Cardiovasc Surg; 2001 Nov 29; 122(5):891-9. PubMed ID: 11689793
    [Abstract] [Full Text] [Related]

  • 19. [Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].
    Flaschka G, Marth E, Desoye G, Freidl W, Walzl M.
    Zentralbl Neurochir; 1990 Nov 29; 51(3):129-37. PubMed ID: 2092546
    [Abstract] [Full Text] [Related]

  • 20. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
    Zhang ZF, Ma JQ, Sun N, Zhang L.
    Zhonghua Wai Ke Za Zhi; 2004 Jul 07; 42(13):817-9. PubMed ID: 15363304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.